Deutsche Bank Ag\ 4 D Molecular Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 121,860 shares of FDMT stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,860

Previous 486,993 74.98%

Holding current value

$2.51 Million

Previous $9.87 Million 60.65%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.03 - $35.87 $6.22 Million - $13.1 Million	-365,133 Reduced 74.98%	121,860 $3.88 Million
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $4.6 Million - $10 Million	471,424 Added 3027.97%	486,993 $9.87 Million
Q3 2023 Nov 09, 2023	SELL	$12.64 - $19.76 $8.35 Million - $13.1 Million	-660,584 Reduced 97.7%	15,569 $198,000
Q2 2023 Aug 14, 2023	BUY	$15.16 - $23.26 $9.03 Million - $13.9 Million	595,886 Added 742.38%	676,153 $12.2 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $81,854 - $122,860	5,298 Added 7.07%	80,267 $1.38 Million

Q4 2022 Feb 13, 2023	BUY	$6.85 - $25.46 $11,295 - $41,983	1,649 Added 2.25%	74,969 $1.67 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $417,787 - $689,109	60,027 Added 451.57%	73,320 $589,000
Q2 2022 Aug 11, 2022	SELL	$5.68 - $15.99 $12,643 - $35,593	-2,226 Reduced 14.34%	13,293 $93,000
Q1 2022 May 13, 2022	SELL	$13.16 - $22.64 $23,214 - $39,936	-1,764 Reduced 10.21%	15,519 $235,000
Q4 2021 Feb 11, 2022	BUY	$19.56 - $32.94 $8,254 - $13,900	422 Added 2.5%	17,283 $379,000
Q3 2021 Nov 04, 2021	BUY	$22.73 - $36.04 $141,380 - $224,168	6,220 Added 58.45%	16,861 $454,000
Q2 2021 Aug 11, 2021	BUY	$22.2 - $42.29 $20,646 - $39,329	930 Added 9.58%	10,641 $257,000
Q1 2021 May 13, 2021	BUY	$35.94 - $52.67 $349,013 - $511,478	9,711 New	9,711 $421,000

Others Institutions Holding FDMT

# of Institutions

157

Shares Held

50.3M

Call Options Held

718K

Put Options Held

370K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $666M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account